Literature DB >> 24898693

Medication complexity and affordability in use of time release antidepressants.

Song H Hong1, Yazed Al-Ruthia, Sunghee Tak.   

Abstract

While time-release (TR) formulations reduce medication complexity, their increased costs may compromise medication affordability. This study examined how medication complexity and affordability affect the extent of access to TR formulations among adult patients with depression. Study subjects consisted of adults (≥ 24 years old) with reported diagnoses of depression from the 2010 Medical Expenditure Panel Survey (MEPS). Antidepressants that offer choices between TR vs. IR (immediate release) were selected. Factors related to medication complexity and affordability were identifi ed based on the Andersonfs model of health services utilization. A multivariate logistic regression was used to examine the study hypotheses while controlling for complex survey sampling in MEPS. A total of 625 working adults with depression had fi lled prescriptions with TR formulations about 60% of the time. Factors related to medication affordability and complexity were signifi cantly associated with the extent of access to TR antidepressant formulations. Identifi cation of those factors associated with the use of TR formulations would contribute to improving access as well as adherence to antidepressant drug therapy.

Entities:  

Keywords:  access to medication; antidepressant drug therapy; medication affordability; medication complexity

Mesh:

Substances:

Year:  2014        PMID: 24898693      PMCID: PMC5350880          DOI: 10.1111/cts.12174

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  16 in total

1.  A systematic review of the associations between dose regimens and medication compliance.

Authors:  A J Claxton; J Cramer; C Pierce
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

2.  Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.

Authors:  Song Hee Hong; Brittany H Sanders; Donna West
Journal:  Curr Med Res Opin       Date:  2006-01       Impact factor: 2.580

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

5.  Physician utilization disparities between the uninsured and insured. Comparisons of the chronically ill, acutely ill, and well nonelderly populations.

Authors:  C Hafner-Eaton
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

6.  Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Authors:  Charles Shelton; Richard Entsuah; S Krishna Padmanabhan; Phillip E Vinall
Journal:  Int Clin Psychopharmacol       Date:  2005-07       Impact factor: 1.659

7.  Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Authors:  Robert N Golden; Charles B Nemeroff; Paul McSorley; Cornelius D Pitts; Eric M Dubé
Journal:  J Clin Psychiatry       Date:  2002-07       Impact factor: 4.384

8.  Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.

Authors:  David V Sheehan; Michael Eaddy; Matthew Sarnes; Tejal Vishalpura; Timothy Regan
Journal:  J Clin Psychopharmacol       Date:  2004-10       Impact factor: 3.153

Review 9.  Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.

Authors:  C Lindsay DeVane
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

10.  Antidepressant reformulations: who uses them, and what are the benefits?

Authors:  Haiden A Huskamp; Alisa B Busch; Marisa E Domino; Sharon-Lise T Normand
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.